Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC
- PMID: 24894422
- DOI: 10.1177/0194599814535183
Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC
Abstract
Objective: Despite advances in interdisciplinary treatment protocols, the chance of cure for recurrent head and neck squamous cell carcinoma (HNSCC) following failed primary therapy is poor and often entails a high morbidity. Recurrence rates vary widely in the literature depending on tumor localization, primary tumor stage, and treatment modality, and only a minority of patients can be salvaged.
Study design: Historical cohort study.
Setting: This study valuates the outcomes of patients treated for recurrent squamous cell carcinoma of the larynx, pharynx, and oral cavity in the largest tertiary referral center of Switzerland to find predictors for survival in salvage surgery with curative intent.
Subjects and methods: Included were 176 consecutive patients with recurrent disease after primary curative treatment of HNSCC, in locations mentioned previously. Kaplan-Meier survival analyses with log-rank testing were performed depending on T and N stage, gender, treatment, and location of first relapse to evaluate the impact on overall survival, disease specific survival, and recurrence free survival.
Results: Overall successful salvage rates were 49.2% for laryngeal recurrence, 35.1% for oral cavity, 32.7% for oropharyngeal, and a mere 17.4% for hypopharyngeal recurrences. Predictive factors for better outcome were location of recurrence, female gender, lymph node status, and extent of salvage treatment.
Conclusion: In case of recurrent disease, laryngeal cancers showed the best salvage rates, whereas in hypopharyngeal relapses, very few patients could be successfully salvaged. Patients therefore should be carefully selected and counseled for salvage treatment according to patient motivation, age, type of previous treatment, surgical resectability, and exclusion of distant recurrence.
Keywords: HNSCC; outcome; salvage rate; squamous cell carcinoma of the head and neck.
© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2014.
Similar articles
-
Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.Head Neck. 2003 Nov;25(11):953-9. doi: 10.1002/hed.10310. Head Neck. 2003. PMID: 14603456
-
Transoral laser microsurgery or total laryngectomy for recurrent squamous cell carcinoma of the larynx: Retrospective analysis of 199 cases.Head Neck. 2017 Jun;39(6):1166-1176. doi: 10.1002/hed.24737. Epub 2017 Mar 2. Head Neck. 2017. PMID: 28252821
-
Factors predictive of successful outcome following salvage treatment of isolated neck recurrences.Otolaryngol Head Neck Surg. 2010 Jun;142(6):832-7. doi: 10.1016/j.otohns.2010.01.024. Otolaryngol Head Neck Surg. 2010. PMID: 20493354
-
Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.Eur Arch Otorhinolaryngol. 2019 Mar;276(3):647-655. doi: 10.1007/s00405-019-05292-0. Epub 2019 Jan 23. Eur Arch Otorhinolaryngol. 2019. PMID: 30673847
-
Surgical management of local and regional recurrent head and neck squamous cell carcinoma.Curr Opin Oncol. 1998 May;10(3):207-12. doi: 10.1097/00001622-199805000-00006. Curr Opin Oncol. 1998. PMID: 9619356 Review.
Cited by
-
MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy.Cancers (Basel). 2022 Dec 12;14(24):6119. doi: 10.3390/cancers14246119. Cancers (Basel). 2022. PMID: 36551604 Free PMC article.
-
Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Results of Polish multicenter observational study.Int J Cancer. 2025 Mar 1;156(5):1074-1084. doi: 10.1002/ijc.35248. Epub 2024 Nov 5. Int J Cancer. 2025. PMID: 39501482 Free PMC article.
-
Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors.J Clin Med. 2023 Feb 7;12(4):1305. doi: 10.3390/jcm12041305. J Clin Med. 2023. PMID: 36835841 Free PMC article.
-
Restoration of the Oral Microbiota After Surgery for Head and Neck Squamous Cell Carcinoma Is Associated With Patient Outcomes.Front Oncol. 2021 Oct 6;11:737843. doi: 10.3389/fonc.2021.737843. eCollection 2021. Front Oncol. 2021. PMID: 34692514 Free PMC article.
-
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Big and Intriguing Challenge Which May Be Resolved by Integrated Treatments Combining Locoregional and Systemic Therapies.Cancers (Basel). 2021 May 14;13(10):2371. doi: 10.3390/cancers13102371. Cancers (Basel). 2021. PMID: 34069092 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical